Viewing Study NCT00787657



Ignite Creation Date: 2024-05-05 @ 8:00 PM
Last Modification Date: 2024-10-26 @ 9:57 AM
Study NCT ID: NCT00787657
Status: COMPLETED
Last Update Posted: 2015-10-16
First Post: 2008-11-06

Brief Title: Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment
Sponsor: Bayer
Organization: Bayer

Study Overview

Official Title: Betaferon Prospective Study on Adherence Coping and Nursing Support
Status: COMPLETED
Status Verified Date: 2015-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BEACON
Brief Summary: The Study analyses the influence of selected factors on adherence to Betaferon treatment in patients with early multiple sclerosis MS The Investigator will document the relevant medical data regarding multiple sclerosis at every hospital visit the patient will fill in two questionnaires at every visit one about coping with the disease and the other about anxiety and depression
The Study particularly looks at the role of the support of the patient given by the multiple sclerosis nursesThe nurse will provide additional standardised information at start of treatment and will regularly phone the patient to ask standardised questions about the general condition with regard to the treatment the disease and social support At the end of the Study it will be assessed if the supportive measures and the standards in terms of adherence management in the hospital have some influence to increase long-term treatment adherence
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
BF0703 OTHER company internal None
311941 OTHER None None